Tag: 2010

Financial

TranS1 Inc. Reports Operating Results for the Second Quarter of 2010, Issues Third Quarter Guidance

WILMINGTON, N.C., Aug. 5, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region, today announced its financial results for the second quarter ended June […]

Financial

BioMimetic Therapeutics Announces Highlights from 2010 Annual Meeting of Stockholders

FRANKLIN, Tenn., Jun 17, 2010 (BUSINESS WIRE) — BioMimetic Therapeutics, Inc. (BMTI 12.64, +0.19, +1.53%)today announced the results of its 2010 Annual Meeting of Stockholders that took place on June 17, 2010 at the Company’s headquarters. The Company’s shareholders voted in favor of all proposals identified in the Proxy Statement. Re-elected to the […]

Financial

Synovis Life Technologies Reports 19 Percent Revenue Growth for Fiscal 2010 Second Quarter

ST. PAUL, Minn.–(BUSINESS WIRE)–Synovis Life Technologies, Inc. (Nasdaq: SYNO), today reported record revenue for the second quarter ended April 30, 2010. “The decline in PSD revenue was due to the impact of increased competition in the buttress market compared to the year-ago period” For the 2010 fiscal second quarter, net […]

Financial

NuVasive (NUVA) Showing 30% to 35% Revenue Growth In 2010; Introduction Of Lateral Access Spine Surgery Critical To Operations

April 19, 2010 – The Wall Street Transcript has just published Medical Devices Reportoffering a timely review of the Health Services sector. This Special Report contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. Please find an excerpt below. Joanne K. Wuensch is a Research […]

Financial

Biomet Announces Financial Results for Third Quarter of Fiscal Year 2010

WARSAW, Ind.–(BUSINESS WIRE)–Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2010. Net sales increased 9% (6% constant currency) to $670 million worldwide, with 6% growth in the U.S. Reconstructive sales, excluding dental, increased 13% (10% constant currency) worldwide, with U.S. growth of 11% Knee […]